Duygu Kuzuoğlu-Öztürk (Duygu Kuzuoglu-Ozturk, Duygu Kuzuoglu-Öztürk)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Regulatory T Cells

Transcription Factor

Top Venues

The EMBO journal

Cancer research

Life science alliance

This page only lists publications with an associated author ORCID identifier.

Publications

Olena Zhulyn, Hannah D Rosenblatt, Leila Shokat, Shizhong Dai, Duygu Kuzuoğlu-Öztürk, Zijian Zhang, Davide Ruggero, Kevan M Shokat, Maria Barna
Evolutionarily divergent mTOR remodels translatome for tissue regeneration. Nature (2023)
Joanna R Kovalski, Duygu Kuzuoğlu-Öztürk, Davide Ruggero
Protein synthesis control in cancer: selectivity and therapeutic targeting. The EMBO journal 41 (8) (2022)
Duygu Kuzuoğlu-Öztürk, Ozlem Aksoy, Christin Schmidt, Robin Lea, Jon D Larson, Ryan R L Phelps, Nicole Nasholm, Megan Holt, Adrian Contreras, Miller Huang, Shannon Wong-Michalak, Hao Shao, Robert J Wechsler-Reya, Joanna J Phillips, Jason E Gestwicki, Davide Ruggero, William A Weiss
N-myc mediated translation control is a therapeutic vulnerability in medulloblastoma. Cancer research (2022)
Duygu Kuzuoğlu-Öztürk
PHGDH and cancer: new job for an old enzyme! The EMBO journal (2022)
Aoife Hanet, Felix Räsch, Ramona Weber, Vincenzo Ruscica, Maria Fauser, Tobias Raisch, Duygu Kuzuoğlu-Öztürk, Chung-Te Chang, Dipankar Bhandari, Catia Igreja, Lara Wohlbold
HELZ directly interacts with CCR4-NOT and causes decay of bound mRNAs. Life science alliance 2 (5) (2019)